Surgical Oncology
Volume 19, Issue 2 , Pages 55-58 , June 2010

Survival analysis in clinical trials: Old tools or new techniques

,Accepted 21 January 2010.

References 

  1. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187
  2. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A. 1972;135:185
  3. Maetani S, Gamel JW. Evolution of cancer survival analysis. Surg Oncol. 2010;
  4. De Gramont A, Hubbard J, Shi Q, O'Connell MJ, Buyse M, Benedetti J, et al. Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT Data Set. J Clin Oncol 2009 Dec 14. (epub ahead of print).
  5. Michiels S, Piedbois P, Burdett S, Syz N, Stewart L, Pignon JP. Meta-analysis when only the median survival times are known: a comparison with individual patient data results. Int J Technol Assess Health Care. 2005;21(1):119–125Winter
  6. Buyse ME, Pignon J, On behalf of the GASTRIC group . Meta-analysis of randomized trials assessing the interest of postoperative adjuvant chemotherapy and prognostic factors in gastric cancer. J Clin Oncol. 2009;27(Suppl.):15;(Abstr 4539)
  7. NICE website . Available at: <http://www.nice.org.uk/>
  8. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359(4):378–390
  9. Wolmark N, Yothers G, O'Connell MJ, Sharif S, Atkins JN, Seay TE, et al. A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: results of NSABP Protocol C-08. J Clin Oncol. 2009;27(Suppl.):18;(abstr LBA4
  10. Appelbaum FR, Dahlberg S, Thomas ED, Buckner CD, Cheever MA, Clift RA, et al. Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparison. Ann Intern Med. 1984;101(5):581–588
  11. Frankel P, Longmate J. Parametric models for accelerated and long-term survival: a comment on proportional hazards. Stat Med. 2002;21(21):3279–3289
  12. Tsodikov AD, Asselain B, Fourque A, Hoang T, Yakovlev A. Discrete strategies of cancer post-treatment surveillance. Estimation and optimization problems. Biometrics. 1995;51(2):437–447
  13. Cox DR, Oakes D. Analysis of survival data. London: Chapman & Hall; 1984;
  14. Nardi A, Schemper M. Comparing Cox and parametric models in clinical studies. Stat Med. 2003;22:3597–3610
  15. Boag JW. Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J R Stat Soc B. 1949;11:15–53

PII: S0960-7404(10)00022-8

doi: 10.1016/j.suronc.2010.01.004

Surgical Oncology
Volume 19, Issue 2 , Pages 55-58 , June 2010

Article Tools